Efficacy of chemotherapy or chemo-anti-PD-1 combination after failed anti-PD-1 therapy for relapsed and refractory Hodgkin lymphoma: a series from Lysa centers

Nom du journal : Am J Hematol

Année : 2018

Volume : doi: 10.1002/ajh.25154 [Epub ahead of print]

Auteurs: Ysebaert L, Herbaux C, Deau B, Bijou F, Rossi C, Filleron T, Ghesquières H, Casasnovas RO, Dupuis J, Kanoun S, Abraham J, Morschhauser F, Brice P, Borel C, Laurent C, Gilhodes J, Maerevoet M, Garciaz S, Oberic L, Lazarovici J, Chauchet A, Stamatoullas-Bastard A, Malfuson JV, Golfier C, Pericart S, Traverse-Glehen A,